Back to Newsroom

Catabasis Names Andrew Nichols, Ph.D., Vice President of Research

CAMBRIDGE, Mass., Feb 26, 2014 – Catabasis Pharmaceuticals Inc. today announced that it has named Andrew Nichols, Ph.D., to the newly-created position of vice president of research. Dr. Nichols brings to Catabasis 25 years of drug development experience, leading efforts from target discovery through translational research and early clinical development for pharmaceutical and biotechnology companies.